To compare different machine-learning approaches, develop the best predictive model for recurrence, and explore interactions between different types of data in non-metastatic nasopharyngeal carcinoma (NPC). Auto Machine Learning (AutoML) classifier plus the minimum redundancy and maximum correlation (mRMR) method achieved the best predictive accuracy to build prediction model for recurrence in NPC. The model incorporating databases including T/N stage data, clinical data, or detailed MRI report findings showed the best performance. Detailed MRI report findings have potential as useful biomarkers in predicting NPC recurrence, which may help develop more individualized multidisciplinary treatment and follow-up strategies.
INTRODUCTION
METHODS
Retrospectively, 792 consecutive non-metastatic NPC patients treated with intensity-modulated radiotherapy from 2010-2013 were enrolled. Seven machine-learning classifiers and four feature selection methods were applied and compared, to establish recurrence models based on T/N stage data, clinical data, detailed MRI report findings, or all of them. The models were evaluated and compared by the mean area under the curve (AUC), test error, sensitivity, and specificity; while the features selected were determined by Cox regression and Kaplan-Meier analysis.RESULTS
Auto Machine Learning (AutoML) classifier plus the minimum redundancy and maximum correlation (mRMR) method achieved the best predictive accuracy of recurrence (Fig.2). The performance of the model incorporating all databases were better than the model based only on T/N stage data, clinical data, or detailed MRI report findings (Fig.2). The model, based only on detailed MRI report findings, exhibited excellent prediction of recurrence with good AUC (0.729) is similar to the all databases model (AUC, 0.730) (Fig.2). Nine independent predictors (invasion of sphenoid sinus, cervical lymph node metastasis, invasion of fossae lateral pharyngeal, invasion of jugular foramen area, bilateral-retropharyngeal lymph node metastasis, bilateral-cervical III/IV/Va region lymph node metastasis in the cluster, invasion of tensor veli palatini muscle, cervical nodal necrosis in ipsilateral III region, invasion of partes ossea tubae pharyngotympaniae) were selected from the best model (Fig.4,5).DISCUSSION
We can effectively identify NPC patients at high-risk of recurrence through the best predictive model, to ensure that close follow-up are arranged for them; and to also ensure that the recurrence can be timely detected for surgical or other appropriate individual strategies, which may improve the clinical outcome4. In our study, detailed MRI report findings were included, which previous studies did not take it into account. Surprisingly, the model only based on detailed MRI report findings exhibited brilliant prediction of recurrence with good AUC similar to the model based on total data.This indicated that detailed MRI report findings made significant contribution prior to the inclusion of clinicopathological factors or TN stage data in the prediction model of NPC recurrence.CONCLUSION
Among several and different ML methods, AutoML classifier plus the mRMR method offered the best prediction value on the recurrence in NPC. The model incorporating databases including T/N stage data, clinical data, or detailed MRI report findings showed the best performance. Detailed MRI report findings have potential as useful biomarkers in predicting recurrence, which may aid individual patients’ strategies selection; thereby improving survivals.1. Feng X, Lin J, Xing S, et al. Higher IGFBP-1 to IGF-1 serum ratio predicts unfavourable survival in patients with nasopharyngeal carcinoma. BMC Cancer. 2017;17:90.
2. Comoretto M, Balestreri L, Borsatti E, et al. Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT. Radiology. 2008;249:203-211.
3. Cruz JA, Wishart DS. Applications of Machine Learning in Cancer Prediction and Prognosis. Cancer Inform. 2007;2:59-77.
4. Tang LQ, Chen DP, Guo L, et al. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 2018;19:461-4